Effect of Curumin (tumeric) on type 2 diabetes

Phase 3

• Conditions: type 2 diabetes mellitus.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT201505301165N4
• Lead Sponsor: Chemical Injuries Research Center, Baqiyatallah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

diagnosis of type 2 diabetes (FBS =126 mg/dl, HbA1C =6.5%); type 2 diabetes patients under standard anti-diabetics agents; adult patients (18 to 65 year old).
Exclusion criteria: pregnancy or breast feeding; lack of compliance with the study medication; impossibility to give informed consent; participation on an other concomitant clinical trial; presence of malignancies; chronic liver disease (ALT = 3 folds of upper limit of normal value range; renal failure (serum creatinine =2.0 mg/dL or on dialysis); subjects receiving hormonal agents; subjects receiving other herbal medicines; subjects with secondary causes of hyperglycemia (receiving steroids or with pancreatic cancer)
subjects with acute infections or chronic inflammatory diseases (rheumatoid arthritis); hypersensitivity to the study medication; endocrine disease (hypothyroidism or hyperthyroidism); obsessive compulsive disorder.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified